Lumiracoxib CAS 220991-20-8
| CAS No. | 220991-20-8 |
| Molecular Formula | C15H13ClFNO2 |
| Molecular Weight | 293.72 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Compared with other compounds in its class, the molecular weight of 293.72 g/mol gives Lumiracoxib distinctive chromatographic separation conditions and mass-spectrometry parameter settings.
CATO supplies Lumiracoxib (CAS 220991-20-8), a certified reference material (molecular formula C15H13ClFNO2, MW 293.72 g/mol) for analytical method development and quality control.
The molecular framework of Lumiracoxib (C15H13ClFNO2) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine/chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
CATO manufactures Lumiracoxib under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C15H13ClFNO2 |
| Molecular Weight | 293.72 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 9.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2020 |
| Halogen Content | F/Cl-containing |
| Nitrogen Atoms | 1 |
Related Lumiracoxib Standards
Recommended Standards
- 4-Chloro-N-[2-(2-fluorophenoxy)ethyl]benzamide (CAS 839693-48-0)
- Methyl 3-chloro-4-[(dimethylsulfamoyl)oxy]benzoate (CAS 338405-92-8)
- 4-Chloro-2-(4-fluorophenyl)-5-(pyrrolidin-1-yl)pyridazin-3(2H)-one (CAS 478049-10-4)
- Methyl 4-chloro-2-((N,N-dimethylsulfamoyl)oxy)benzoate (CAS 900014-78-0)
- 1-Methyl-2-oxo-2,3-dihydro-1H-indole-5-carboxylic acid (CAS 167627-05-6)
- 5-(4-Chlorophenyl)-2-methylfuran-3-carbonyl chloride (CAS 175276-63-8)
- 4-(2-Bromoacetyl)-2-chloro-benzonitrile (CAS 182626-08-0)
- 2-[3-(Benzenesulfonyl)-4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy]-3-chloro-5-(trifluoromethyl)pyridine (CAS 338406-80-7)
- Sumatriptan impurity 4 (CAS CATO-C4X-17574)
- Thiophene-3,4-diamine dihydrochloride (CAS 90069-81-1)
- 2-Amino-5-methyl-4-(p-tolyl)thiophene-3-carbonitrile (CAS 438613-84-4)
- tert-Butyl 5-bromo-2H-spiro[benzofuran-3,4'-piperidine]-1'-carboxylate (CAS 1251015-16-3)
- 2-(1,3-dihydro-2-benzofuran-5-sulfonamido)acetic acid (CAS 1240527-08-5)
- Neuropeptide Y (22-36) (CAS 119019-65-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com